Tag: PBS
-
Not all diseases equal at PBS, says LEO
- 23 Jun 2021
Eight cancer drugs PBS listed since August and only one eczema drug in 20 years reveal PBS favouritism, says Leo Pharma’s Ruchi Kanojia.
Read more -
Sixteen drugs on PBS doorstep
- 02 Jun 2021
With just four new additions to the PBS in June, the waitlist of PBAC recommended products includes a number failing to progress.
Read more -
Labor meds policy in development: Butler
- 24 May 2021
Labor health spokesman Mark Butler answered questions on medicines policy following his post-Budget address on Friday. MedNews was there.
Read more -
Roche pulls Avastin from PBS
- 24 May 2021
Roche withdraws cancer drug Avastin from PBS as the ninth biologic to face biosimilar competition decides not to fight it out.
Read more -
One in three cancer drugs get PBAC tick
- 17 May 2021
UQ academic analysed 179 PBAC submissions to find price the main reason drugs get rejected while the Managed Access Program was used by PBAC just three times in eight years.
Read more -
Budget reveals $16B in rebates
- 12 May 2021
Budget spend is set to rise a little then fall as price cuts and generics erode short-term gains. Full Budget 2021 coverage and comment in today’s MedNews.
Read more -
Lonely newcomer in April PBS listings
- 29 Mar 2021
While some big names will have funded access expanded, only one new drug will be added to the PBS in April.
Read more -
Chronic conditions cost $38B a year: Productivity Commission
- 24 Mar 2021
New report out today says “still significant scope to mitigate the effects of chronic conditions”.
Read more